Report cover image

Global Intravenous Immunoglobulin Market Size- By Application, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published May 30, 2025
Length 262 Pages
SKU # SPER20187063

Description

Intravenous Immunoglobulin Market Introduction and Overview

According to SPER market research, ‘Global Intravenous Immunoglobulin Market Size- By Application, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Intravenous Immunoglobulin Market is predicted to reach 28.52 billion by 2034 with a CAGR of 7.49%.

A blood product called intravenous immunoglobulin (IVIG) is created from pooled plasma donations and contains immunoglobulins, primarily IgG antibodies. It is used to treat a range of immune-related conditions, such as autoimmune illnesses, inflammatory disorders, and primary and secondary immunodeficiencies.

Restraints:

The intravenous immunoglobulin (IVIG) market has various difficulties that limit its growth and accessibility. One major difficulty is the high capital and operating costs involved with IVIG production. The procedure entails collecting large amounts of donor plasma, followed by intensive production and testing to assure safety and efficacy. These tight procedures increase operational costs, which are then passed on to patients, reducing accessibility and affordability.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered

By Application, By Distribution Channel

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered

Baxter, BDI Pharma Inc., Biotest AG, China Biologics Products Inc., CSL, Grifols SA, Kedrion, LFB, Octapharma AG and others.

Global Intravenous Immunoglobulin Market Segmentation:

By Application:

Based on the Application, Global Intravenous Immunoglobulin Market is segmented as; Immunodeficiency diseases, CIDP, Hypogammaglobulinemia, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis and Multifocal motor neuropathy

By Distribution Channel:

Based on the Distribution Channel, Global Intravenous Immunoglobulin Market is segmented as; Hospital Pharmacies, Specialty Pharmacies and Other.

By Region:

This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

262 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Intravenous ImmunoglobulinMarket Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Intravenous ImmunoglobulinMarket
7. Global Intravenous ImmunoglobulinMarket, By Application (USD Million) 2025-2034
7.1. Immunodeficiency diseases
7.2. CIDP
7.3. Hypogammaglobulinemia
7.4. Congenital AIDS
7.5. Chronic Lymphocytic Leukemia
7.6. Myasthenia Gravis
7.7. Multifocal motor neuropathy
8. Global Intravenous ImmunoglobulinMarket, By Distribution Channel (USD Million) 2025-2034
8.1. Hospital Pharmacies
8.2. Specialty Pharmacies
8.3. Other
9. Global Intravenous ImmunoglobulinMarket Forecast, 2025-2034 (USD Million)
9.1. Global Intravenous ImmunoglobulinMarket Size and Market Share
10. Global Intravenous ImmunoglobulinMarket, By Region, 2025-2034 (USD Million)
10.1. Asia-Pacific
10.1.1. Australia
10.1.2. China
10.1.3. India
10.1.4. Japan
10.1.5. South Korea
10.1.6. Rest of Asia-Pacific
10.2. Europe
10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Spain
10.2.5. United Kingdom
10.2.6. Rest of Europe
10.3. Middle East and Africa
10.3.1. Kingdom of Saudi Arabia
10.3.2. United Arab Emirates
10.3.3. Qatar
10.3.4. South Africa
10.3.5. Egypt
10.3.6. Morocco
10.3.7. Nigeria
10.3.8. Rest of Middle-East and Africa
10.4. North America
10.4.1. Canada
10.4.2. Mexico
10.4.3. United States
10.5. Latin America
10.5.1. Argentina
10.5.2. Brazil
10.5.3. Rest of Latin America
11. Company Profile
11.1. Baxter
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. BDI Pharma Inc.
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Biotest AG
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. China Biologics Products Inc.
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. CSL
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Grifols SA
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Kedrion
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. LFB
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Octapharma AG
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us